Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01701024 · ClinicalTrials.gov registry record · Phase 3
Clinical Study to Test the Efficacy and Safety of ACYC to Treat Moderate to Severe Acne
A Phase 3 study, sponsored by Bausch Health Americas.
- Completed
- Registry status
- Phase 3
- Development phase
- 498
- Enrollment target
NCT01701024: Completed Phase 3 study, sponsored by Bausch Health Americas.
NCT01701024 is a Phase 3 study that has completed, run by Bausch Health Americas. The registered enrollment target is 498 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (35% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01701024, a Phase 3 study, has completed, sponsored by Bausch Health Americas.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 498 participants
- Enrollment target
Study Summary
The primary objective of this study is to compare the efficacy and safety and tolerability of ACYC Gel and vehicle in the treatment of subjects with Acne Vulgaris.
Interventions
- DRUG ACYC
- DRUG ACYC vehicle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 498 participants |
| Start Date | 2012-10 |
| Est. Completion | 2013-07 |
| Phase | Phase 3 |
What the finished NCT01701024 record still lists
NCT01701024 is an interventional study that assigns participants to a tested intervention. The registered 498 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (35% lower).
The record links to 0 conditions, and to 2 interventions - of which ACYC is the first listed.
NCT01701024 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01701024 about?
NCT01701024 is a clinical study titled "Clinical Study to Test the Efficacy and Safety of ACYC to Treat Moderate to Severe Acne". The primary objective of this study is to compare the efficacy and safety and tolerability of ACYC Gel and vehicle in the treatment of subjects with Acne Vulgaris.
What is the current status of trial NCT01701024?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 498 participants. The study started on 2012-10. Estimated completion is 2013-07.
What interventions are being tested in trial NCT01701024?
The interventions under investigation include: ACYC (DRUG), ACYC vehicle (DRUG).
Who is sponsoring clinical trial NCT01701024?
This trial is sponsored by Bausch Health Americas, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01701024's enrollment target sits among peer trials
498 775th of 2000 higher than 1,226 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04137900 · 499 participants · Phase 1
Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced Malignancies
- NCT06733480 · 499 participants · NA
Innovating Physical Therapy: A Pilot Study on Band Connect's Impact on Compliance, Satisfaction, and Revenue
- NCT03175224 · 497 participants · Phase 2
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
- NCT05301816 · 497 participants · NA
PDN Post Market, Multicenter, Prospective, Global Clinical Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia